These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 23856047

  • 1. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
    Song WH, Liu MM, Zhong DW, Zhu YL, Bosscher M, Zhou L, Ye DY, Yuan ZH.
    Bioorg Med Chem Lett; 2013 Aug 15; 23(16):4528-31. PubMed ID: 23856047
    [Abstract] [Full Text] [Related]

  • 2. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication.
    Zhu R, Wang M, Xia Y, Qu F, Neyts J, Peng L.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3321-7. PubMed ID: 18445526
    [Abstract] [Full Text] [Related]

  • 3. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.
    Çıkla-Süzgün P, Kaushik-Basu N, Basu A, Arora P, Talele TT, Durmaz I, Çetin-Atalay R, Küçükgüzel ŞG.
    J Enzyme Inhib Med Chem; 2015 Jun 01; 30(5):778-85. PubMed ID: 25676325
    [Abstract] [Full Text] [Related]

  • 4. Structure based medicinal chemistry approach to develop 4-methyl-7-deazaadenine carbocyclic nucleosides as anti-HCV agent.
    Thiyagarajan A, Salim MT, Balaraju T, Bal C, Baba M, Sharon A.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7742-7. PubMed ID: 23122860
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of low molecular weight compounds with complement inhibition activity.
    Master HE, Khan SI, Poojari KA.
    Bioorg Med Chem; 2005 Aug 15; 13(16):4891-9. PubMed ID: 15978815
    [Abstract] [Full Text] [Related]

  • 6. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
    Wittine K, Stipković Babić M, Makuc D, Plavec J, Kraljević Pavelić S, Sedić M, Pavelić K, Leyssen P, Neyts J, Balzarini J, Mintas M.
    Bioorg Med Chem; 2012 Jun 01; 20(11):3675-85. PubMed ID: 22555152
    [Abstract] [Full Text] [Related]

  • 7. S-aryltriazole acyclonucleosides: synthesis and biological evaluation against hepatitis C virus.
    Liu Y, Xia Y, Li W, Cong M, Maggiani A, Leyssen P, Qu F, Neyts J, Peng L.
    Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3610-3. PubMed ID: 20483607
    [Abstract] [Full Text] [Related]

  • 8. Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation.
    Zhang H, Zheng X, Li J, Liu Q, Huang XX, Ding H, Suzuki R, Muramatsu M, Song SJ.
    Eur J Med Chem; 2021 Jun 05; 218():113395. PubMed ID: 33838584
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus.
    Youssif BG, Mohamed YA, Salim MT, Inagaki F, Mukai C, Abdu-Allah HH.
    Acta Pharm; 2016 Jun 01; 66(2):219-31. PubMed ID: 27279065
    [Abstract] [Full Text] [Related]

  • 10. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses.
    Peng HK, Chen WC, Lee JC, Yang SY, Tzeng CC, Lin YT, Yang SC.
    Org Biomol Chem; 2013 Mar 21; 11(11):1858-66. PubMed ID: 23377187
    [Abstract] [Full Text] [Related]

  • 11. An alternative route to the arylvinyltriazole nucleosides.
    Chudinov MV, Prutkov AN, Matveev AV, Grebenkina LE, Konstantinova ID, Berezovskaya YV.
    Bioorg Med Chem Lett; 2016 Jul 15; 26(14):3223-3225. PubMed ID: 27262598
    [Abstract] [Full Text] [Related]

  • 12. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
    Windisch MP, Jo S, Kim HY, Kim SH, Kim K, Kong S, Jeong H, Ahn S, No Z, Hwang JY.
    Eur J Med Chem; 2014 May 06; 78():35-42. PubMed ID: 24675178
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A, Gurukumar KR, Basu A, Patel MR, Kaushik-Basu N, Talele TT.
    Eur J Med Chem; 2011 Oct 06; 46(10):5138-45. PubMed ID: 21893371
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
    Moltzen EK, Pedersen H, Bøgesø KP, Meier E, Frederiksen K, Sánchez C, Løve Lembøl H.
    J Med Chem; 1994 Nov 25; 37(24):4085-99. PubMed ID: 7990109
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antiviral evaluation of novel 5-(N-Aryl-aminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazoles and pyrazolyl derivatives.
    Abdel-Aal MT, El-Sayed WA, El-Kosy SM, El-Ashry el SH.
    Arch Pharm (Weinheim); 2008 May 25; 341(5):307-13. PubMed ID: 18404774
    [Abstract] [Full Text] [Related]

  • 18. C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus.
    Chen YL, Zacharias J, Vince R, Geraghty RJ, Wang Z.
    Bioorg Med Chem; 2012 Aug 01; 20(15):4790-800. PubMed ID: 22748708
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication.
    Ban S, Ueda Y, Ohashi M, Matsuno K, Ikeda M, Kato N, Miyachi H.
    Bioorg Med Chem Lett; 2013 Sep 01; 23(17):4774-8. PubMed ID: 23891183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.